Mar 13, 2023 | Politics

Pfizer Acquires Biotech Firm Specializing In Cancer Treatments For $43 Billion

Pfizer Acquires Biotech Firm Specializing In Cancer Treatments For $43 Billion

Pharmaceutical giant Pfizer expanded its profile on Monday to access cancer treatments.

Why would the COVID-19 jab manufacturer need to specialize in cancer treatments?

Perhaps it’s another case of Big Pharma providing the ‘cure’ for the illness they created?

WATCH: Dr. Ryan Cole Reports 20X Increase of Cancers & Autoimmune Diseases in Vaccinated Patients

Pfizer announced that it acquired Seagen, a biotech firm that specializes in innovative cancer treatments, for $43 billion.

The Pharma giant said it would pay $229 a share in cash.

“We are not buying the golden eggs,” Pfizer CEO Albert Bourla reportedly said.

“We are acquiring the goose that is laying the golden eggs.”

Source link

We are only showing you a preview of the content, we are curating news worth reading and sharing. Please follow the source link above to read the full content.

Telegram comments:

we use telegram comments to deter spammers.